Small cationic antimicrobial peptides delocalize peripheral membrane proteins

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 14, 2014, Pages

  Wenzel, Michaela ^a   Chiriac, Alina Iulia ^b   Otto, Andreas ^c   Zweytick, Dagmar ^d   May, Caroline ^a   Schumacher, Catherine ^e   Gust, Ronald ^f   Albada, H Bauke ^a   Penkova, Maya ^a   Krämer, Ute ^a   Erdmann, Ralf ^a   Metzler Nolte, Nils ^a   Straus, Suzana K ^g   Bremer, Erhard ^h   Becher, Dörte ^c   Brötz Oesterhelt, Heike ^e   Sahl, Hans Georg ^b   Bandow, Julia Elisabeth ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d UNIVERSITY OF GRAZ   (Austria)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY OF INNSBRUCK   (Austria)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Hypoosmotic stress response; Mechanism of action; Metallocenes; Respiratory chain

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; ARGININE; CYTOCHROME C; GLUTAMIC ACID; GRAMICIDIN S; MEMBRANE PROTEIN; MP 196; MP 276; PROTEOME; RUTHENIUM; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BACILLUS SUBTILIS; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BINDING SITE; BIOSYNTHESIS; CELL ENERGY; CELL STRUCTURE; CELLULAR DISTRIBUTION; CHANNEL GATING; CONTROLLED STUDY; DNA DAMAGE; GRAM POSITIVE BACTERIUM; HOMEOSTASIS; HYPOOSMOTIC STRESS; IN VIVO STUDY; MACROMOLECULE; MEMBRANE DEPOLARIZATION; NONHUMAN; PHARMACOPHORE; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RESPIRATORY CHAIN; RNA SYNTHESIS; STEREOSPECIFICITY; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; WESTERN BLOTTING;

HYPOOSMOTIC STRESS RESPONSE; MECHANISM OF ACTION; METALLOCENES; RESPIRATORY CHAIN;

ANTIMICROBIAL CATIONIC PEPTIDES; BACILLUS SUBTILIS; BINDING SITES; CYTOCHROMES C; HOMEOSTASIS; LIPID BILAYERS; MEMBRANE PROTEINS; PHOSPHOLIPIDS;

EID: 84898039132     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1319900111     Document Type: Article

References (88)

1. Giuliani A, Pirri G, Nicoletto SF (2007) Antimicrobial peptides: An overview of a promising class of therapeutics. Cent Eur J Biol 2(1):1-33.
2. Riedl S, Zweytick D, Lohner K (2011) Membrane-active host defense peptides-challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids 164(8):766-781.
3. Mygind PH, et al. (2005) Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437(7061):975-980.
4. Schneider T, et al. (2010) Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 328(5982):1168-1172.
5. Patra M, Gasser G, Metzler-Nolte N (2012) Small organometallic compounds as antibacterial agents. Dalton Trans 41(21):6350-6358.
6. Pag U, et al. (2008) Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an alpha-helical 'sequence template'. J Antimicrob Chemother 61(2):341-352.
7. Zelezetsky I, Tossi A (2006) Alpha-helical antimicrobial peptides-using a sequence template to guide structure-activity relationship studies. Biochim Biophys Acta 1758(9):1436-1449.
8. Zelezetsky I, et al. (2005) Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: Effect on mode of action and cell specificity. Biochem J 390(Pt 1):177-188.
9. Rathinakumar R, Walkenhorst WF, Wimley WC (2009) Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: The importance of interfacial activity. J Am Chem Soc 131(22):7609-7617.
10. Sharma RK, Sundriyal S, Wangoo N, Tegge W, Jain R (2010) New antimicrobial hexapeptides: Synthesis, antimicrobial activities, cytotoxicity, and mechanistic studies. ChemMedChem 5(1):86-95.
11. Wimley WC, Hristova K (2011) Antimicrobial peptides: Successes, challenges and unanswered questions. J Membr Biol 239(1-2):27-34.
12. Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55(1):27-55.
13. Chan DI, Prenner EJ, Vogel HJ (2006) Tryptophan-and arginine-rich antimicrobial peptides: Structures and mechanisms of action. Biochim Biophys Acta 1758(9): 1184-1202.
14. Zweytick D, et al. (2011) Studies on lactoferricin-derived Escherichia coli membraneactive peptides reveal differences in the mechanism of N-acylated versus nonacylated peptides. J Biol Chem 286(24):21266-21276.
15. Zweytick D, Tumer S, Blondelle SE, Lohner K (2008) Membrane curvature stress and antibacterial activity of lactoferricin derivatives. Biochem Biophys Res Commun 369(2):395-400.
16. Chantson JT, Verga Falzacappa MV, Crovella S, Metzler-Nolte N (2006) Solid-phase synthesis, characterization, and antibacterial activities of metallocene-peptide bioconjugates. ChemMedChem 1(11):1268-1274.
17. Strøm MB, et al. (2003) The pharmacophore of short cationic antibacterial peptides. J Med Chem 46(9):1567-1570.
18. Albada HB, et al. (2012) Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups. Beilstein J Org Chem 8:1753-1764.
19. Albada HB, et al. (2012) Tuning the activity of short Arg-Trp antimicrobial peptides by lipidation of C-or N-terminal lysine side-chain. ACS Med Chem Lett 3(12):980-984.
20. Albada HB, et al. (2013) Short antibacterial peptides with significantly reduced hemolytic activity can be identified by a systematic L-to-D exchange scan of their amino acid residues. ACS Comb Sci 15(11):585-592.
21. Urban A, et al. (2007) Novel whole-cell antibiotic biosensors for compound discovery. Appl Environ Microbiol 73(20):6436-6443.
22. Brötz-Oesterhelt H, et al. (2005) Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat Med 11(10):1082-1087.
23. Bandow JE (2005) Proteomic approaches to antibiotic drug discovery. Curr Protoc Microbiol Chapter 1:2.
24. Bandow JE, Brötz H, Leichert LI, Labischinski H, Hecker M (2003) Proteomic approach to understanding antibiotic action. Antimicrob Agents Chemother 47(3):948-955.
25. Wenzel M, et al. (2011) Proteomic signature of fatty acid biosynthesis inhibition available for in vivo mechanism-of-action studies. Antimicrob Agents Chemother 55(6):2590-2596.
26. Wenzel M, et al. (2012) Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane. Antimicrob Agents Chemother 56(11):5749-5757.
27. Katsu T, et al. (1989) Mechanism of membrane damage induced by the amphipathic peptides gramicidin S and melittin. Biochim Biophys Acta 983(2):135-141.
28. Gross A, et al. (2012) A ruthenocene-PNA bioconjugate-synthesis, characterization, cytotoxicity, and AAS-detected cellular uptake. Bioconjug Chem 23(9):1764-1774.
29. Matias VR, Beveridge TJ (2005) Cryo-electron microscopy reveals native polymeric cell wall structure in Bacillus subtilis 168 and the existence of a periplasmic space. Mol Microbiol 56(1):240-251.
30. Matias VR, Beveridge TJ (2008) Lipoteichoic acid is a major component of the Bacillus subtilis periplasm. J Bacteriol 190(22):7414-7418.
31. Weidenmaier C, Peschel A (2008) Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol 6(4):276-287.
32. Clejan S, Krulwich TA, Mondrus KR, Seto-Young D (1986) Membrane lipid composition of obligately and facultatively alkalophilic strains of Bacillus spp. J Bacteriol 168(1):334-340.
33. Brisebois PP, Arnold AA, Chabre YM, Roy R, Marcotte I (2012) Comparative study of the interaction of fullerenol nanoparticles with eukaryotic and bacterial model membranes using solid-state NMR and FTIR spectroscopy. Eur Biophys J 41(6):535-544.
34. Duax WL, et al. (1996) Molecular structure and mechanisms of action of cyclic and linear ion transport antibiotics. Biopolymers 40(1):141-155.
35. Strahl H, Hamoen LW (2010) Membrane potential is important for bacterial cell division. Proc Natl Acad Sci USA 107(27):12281-12286.
36. Andrés MT, Fierro JF (2010) Antimicrobial mechanism of action of transferrins: Selective inhibition of H+-ATPase. Antimicrob Agents Chemother 54(10):4335-4342.
37. Mogi T, Ui H, Shiomi K, Omura S, Kita K (2008) Gramicidin S identified as a potent inhibitor for cytochrome bd-type quinol oxidase. FEBS Lett 582(15):2299-2302.
38. Vonck J, Schäfer E (2009) Supramolecular organization of protein complexes in the mitochondrial inner membrane. Biochim Biophys Acta 1793(1):117-124.
39. Hoffmann T, Boiangiu C, Moses S, Bremer E (2008) Responses of Bacillus subtilis to hypotonic challenges: Physiological contributions of mechanosensitive channels to cellular survival. Appl Environ Microbiol 74(8):2454-2460.
40. Sitaram N, Nagaraj R (1999) Interaction of antimicrobial peptides with biological and model membranes: Structural and charge requirements for activity. Biochim Biophys Acta 1462(1-2):29-54.
41. Epand RM, et al. (2010) Lipid clustering by three homologous arginine-rich antimicrobial peptides is insensitive to amino acid arrangement and induced secondary structure. Biochim Biophys Acta 1798(6):1272-1280.
42. Fuertes G, Giménez D, Esteban-Martín S, Sánchez-Muñoz OL, Salgado J (2011) A lipocentric view of peptide-induced pores. Eur Biophys J 40(4):399-415.
43. Schibli DJ, Epand RF, Vogel HJ, Epand RM (2002) Tryptophan-rich antimicrobial peptides: Comparative properties and membrane interactions. Biochem Cell Biol 80(5):667-677.
44. Rezansoff AJ, et al. (2005) Interactions of the antimicrobial peptide Ac-FRWWHRNH( 2) with model membrane systems and bacterial cells. J Pept Res 65(5):491-501.
45. Scheinpflug K, Nikolenko H, Komarov IV, Rautenbach M, Dathe M (2013) What goes around comes around-a comparative study of the influence of chemical modifications on the antimicrobial properties of small cyclic peptides. Pharmaceuticals (Basel) 6(9): 1130-1144.
46. Spindler EC, Hale JD, Giddings TH, Jr., Hancock RE, Gill RT (2011) Deciphering the mode of action of the synthetic antimicrobial peptide Bac8c. Antimicrob Agents Chemother 55(4):1706-1716.
47. Mann PA, et al. (2013) Murgocil is a highly bioactive staphylococcal-specific inhibitor of the peptidoglycan glycosyltransferase enzyme MurG. ACS Chem Biol 8(11):2442-2451.
48. Pogliano J, Pogliano N, Silverman JA (2012) Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins. J Bacteriol 194(17):4494-4504.
49. Bayer AS, Schneider T, Sahl H-G (2013) Mechanisms of daptomycin resistance in Staphylococcus aureus: Role of the cell membrane and cell wall. Ann N Y Acad Sci 1277:139-158.
50. Lenarcic R, et al. (2009) Localisation of DivIVA by targeting to negatively curved membranes. EMBO J 28(15):2272-2282.
51. Wecke T, et al. (2009) Daptomycin versus Friulimicin B: In-depth profiling of Bacillus subtilis cell envelope stress responses. Antimicrob Agents Chemother 53(4):1619-1623.
52. Ha S, Walker D, Shi Y, Walker S (2000) The 1.9 A crystal structure of Escherichia coli MurG, a membrane-associated glycosyltransferase involved in peptidoglycan biosynthesis. Protein Sci 9(6):1045-1052.
53. Bengtsson J, Tjalsma H, Rivolta C, Hederstedt L (1999) Subunit II of Bacillus subtilis cytochrome c oxidase is a lipoprotein. J Bacteriol 181(2):685-688.
54. Bengtsson J, Rivolta C, Hederstedt L, Karamata D (1999) Bacillus subtilis contains two small c-type cytochromes with homologous heme domains but different types of membrane anchors. J Biol Chem 274(37):26179-26184.
55. Fränzel B, et al. (2010) Corynebacterium glutamicum exhibits a membrane-related response to a small ferrocene-conjugated antimicrobial peptide. J Biol Inorg Chem 15(8):1293-1303.
56. López D, Kolter R (2010) Functional microdomains in bacterial membranes. Genes Dev 24(17):1893-1902.
57. Kingston AW, Subramanian C, Rock CO, Helmann JD (2011) A ωW-dependent stress response in Bacillus subtilis that reduces membrane fluidity. Mol Microbiol 81(1): 69-79.
58. Wolf D, et al. (2010) In-depth profiling of the LiaR response of Bacillus subtilis. J Bacteriol 192(18):4680-4693.
59. Kobayashi R, Suzuki T, Yoshida M (2007) Escherichia coli phage-shock protein A (PspA) binds to membrane phospholipids and repairs proton leakage of the damaged membranes. Mol Microbiol 66(1):100-109.
60. Bertsche U, et al. (2011) Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation. Antimicrob Agents Chemother 55(8):3922-3928.
61. Rose WE, Fallon M, Moran JJ, Vanderloo JP (2012) Vancomycin tolerance in methicillin-resistant Staphylococcus aureus: Influence of vancomycin, daptomycin, and telavancin on differential resistance gene expression. Antimicrob Agents Chemother 56(8):4422-4427.
62. Saar-Dover R, et al. (2012) D-alanylation of lipoteichoic acids confers resistance to cationic peptides in group B streptococcus by increasing the cell wall density. PLoS Pathog 8(9):e1002891.
63. Booth IR, Blount P (2012) The MscS and MscL families of mechanosensitive channels act as microbial emergency release valves. J Bacteriol 194(18):4802-4809.
64. Henry G, Deleu M, Jourdan E, Thonart P, Ongena M (2011) The bacterial lipopeptide surfactin targets the lipid fraction of the plant plasma membrane to trigger immunerelated defence responses. Cell Microbiol 13(11):1824-1837.
65. Desoignies N, Schramme F, Ongena M, Legrève A (2013) Systemic resistance induced by Bacillus lipopeptides in Beta vulgaris reduces infection by the rhizomania disease vector Polymyxa betae. Mol Plant Pathol 14(4):416-421.
66. Brotman Y, Makovitzki A, Shai Y, Chet I, Viterbo A (2009) Synthetic ultrashort cationic lipopeptides induce systemic plant defense responses against bacterial and fungal pathogens. Appl Environ Microbiol 75(16):5373-5379.
67. Whatmore AM, Chudek JA, Reed RH (1990) The effects of osmotic upshock on the intracellular solute pools of Bacillus subtilis. J Gen Microbiol 136(12):2527-2535.
68. Hoffmann T, et al. (2012) Synthesis, release, and recapture of compatible solute proline by osmotically stressed Bacillus subtilis cells. Appl Environ Microbiol 78(16): 5753-5762.
69. Hoffmann T, et al. (2013) Osmotic control of opuA expression in Bacillus subtilis and its modulation in response to intracellular glycine betaine and proline pools. J Bacteriol 195(3):510-522.
70. Zaprasis A, et al. (2013) Osmoprotection of Bacillus subtilis through import and proteolysis of proline-containing peptides. Appl Environ Microbiol 79(2):576-587.
71. Ajouz B, Berrier C, Garrigues A, Besnard M, Ghazi A (1998) Release of thioredoxin via the mechanosensitive channel MscL during osmotic downshock of Escherichia coli cells. J Biol Chem 273(41):26670-26674.
72. Becker M, et al. (2013) Glutamate efflux mediated by Corynebacterium glutamicum MscCG, Escherichia coli MscS, and their derivatives. Biochim Biophys Acta 1828(4): 1230-1240.
73. Kouwen TR, et al. (2009) The large mechanosensitive channel MscL determines bacterial susceptibility to the bacteriocin sublancin 168. Antimicrob Agents Chemother 53(11):4702-4711.
74. Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI (1998) Activities of LL-37, a cathelinassociated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 42(9):2206-2214.
75. Koo SP, Yeaman MR, Bayer AS (1996) Staphylocidal action of thrombin-induced platelet microbicidal protein is influenced by microenvironment and target cell growth phase. Infect Immun 64(9):3758-3764.
76. Schneider T, et al. (2004) In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus. Mol Microbiol 53(2):675-685.
77. Otto A, et al. (2010) Systems-wide temporal proteomic profiling in glucose-starved Bacillus subtilis. Nat Commun 1:137.
78. Eymann C, et al. (2004) A comprehensive proteome map of growing Bacillus subtilis cells. Proteomics 4(10):2849-2876.
79. Wolff S, Hahne H, Hecker M, Becher D (2008) Complementary analysis of the vegetative membrane proteome of the human pathogen Staphylococcus aureus. Mol Cell Proteomics 7(8):1460-1468.
80. Vizcaíno JA, et al. (2013) The PRoteomics IDEntifications (PRIDE) database and associated tools: Status in 2013. Nucleic Acids Res 41(Database issue):D1063-D1069.
81. Santhana Raj L, et al. (2007) Rapid method for transmission electron microscopy study of Staphylococcus aureus ATCC 25923. Annals of Microscopy 7:102-108.
82. Gust R, et al. (1998) Stability and cellular studies of [rac-1,2-bis(4-fluorophenyl)-ethylenediamine][cyclobutane-1,1-dicarboxylato] platinum(II), a novel, highly active carboplatin derivative. J Cancer Res Clin Oncol 124(11):585-597.
83. Schäfer S, Ott I, Gust R, Sheldrick WS (2007) Influence of the polypyridyl (pp) ligand size on the DNA binding properties, cytotoxicity and cellular uptake of organoruthenium( II) complexes of the type [(ν6-C6Me6)Ru(L)(pp)]n+. Eur J Inorg Chem 19:3034-3046.
84. Schatzschneider U, et al. (2008) Cellular uptake, cytotoxicity, and metabolic profiling of human cancer cells treated with ruthenium(II) polypyridyl complexes [Ru(bpy)2 (N-N)]Cl2 with N-N=bpy, phen, dpq, dppz, and dppn. ChemMedChem 3(7): 1104-1109.
85. Burstein C, Tiankova L, Kepes A (1979) Respiratory control in Escherichia coli K. Eur J Biochem 94(2):387-392
86. Palmgren MG, Sommarin M, Ulvskov P, Larsson C (1990) Effect of detergents on the H(+)-ATPase activity of inside-out and right-side-out plant plasma membrane vesicles. Biochim Biophys Acta 1021(2):133-140.
87. Smith JJ, McFeters GA (1997) Mechanisms of INT (2-(4-iodophenyl)-3-(4- nitrophenyl)-5-phenyl tetrazolium chloride), and CTC (5-cyano-2,3-ditolyl tetrazolium chloride) reduction in Escherichia coli K-12. J Microbiol Methods 29(1):161-175.
88. Schmitt P, et al. (2010) Insight into invertebrate defensin mechanism of action: Iyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II. J Biol Chem 285(38):29208-29216.